3 Labeling for orforglipron and related agents includes warnings for acute pancreatitis, gallbladder disease, acute kidney injury (often secondary to dehydration), hypersensitivity reactions, and diabetic retinopathy complications
DPP-4 inhibitors for treating diabetes Just as exenatide was making its way to approval for type 2 diabetes, another type of drug had appeared on the scene for the disease
I dont have the scientific evidence to prove it (yet), but as I look at the extreme side effects many people experience (nausea, fainting, pancreatitis, dampening reward systems, gas, etc.) its clear to me that the drugs are fighting the natural order of how our bodies function and I have major concerns for how this will impact us in ways we dont yet see
Powerful Antioxidant Glutathione neutralizes free radicals generated by exposure to UV rays, pollution, and other environmental factors